ProCE Banner Activity

An Update on Biomarkers in NSCLC Clinical Management


Learn about the latest updates on biomarker testing and personalized therapy for patients with NSCLC, including considerations for treatment selection and AE management.

Released: April 20, 2023



Rasheda Persinger

Rasheda Persinger, MSN, AGNP-C, AOCNP

Lead Nurse Practitioner
Division of Medical Oncology
Johns Hopkins University
Washington, DC

Provided by

Provided by Partners for Advancing Clinical Education (PACE)

ProCE Banner


Supported by an educational grant from Merck Sharp & Dohme LLC, and Novartis Pharmaceuticals Corporation.

Merck Sharp & Dohme, LLC

Novartis Pharmaceuticals Corporation